HBM HEALTHCARE INVESTMENTS AG (FRA:CH001262) EQS-Adhoc: Successful debut on the stock exchange for HBM portfolio company Longboard Pharmaceuticals
Transparency directive : regulatory news
|
EQS Group-Ad-hoc: HBM Healthcare Investments AG / Key word(s): IPO Longboard Pharmaceuticals (Nasdaq: LBPH), a private company in the portfolio of HBM Healthcare Investments, completed its IPO last Friday. The company raised USD 80 million in new capital by issuing 5 million shares at a price of USD 16.00 each. On the first day of trading, the share price closed at USD 16.65 (+4.1%).
End of ad hoc announcement |
| Language: | English |
| Company: | HBM Healthcare Investments AG |
| Bundesplatz 1 | |
| 6300 Zug | |
| Switzerland | |
| Phone: | +41438887171 |
| Fax: | +41438887172 |
| E-mail: | info@hbmhealthcare.com |
| Internet: | https://www.hbmhealthcare.com |
| ISIN: | CH0012627250 |
| Valor: | 1262725 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1175438 |
| End of Announcement | EQS Group News Service |
|
|
1175438 15-March-2021 CET/CEST